Sunovion
在场
Sunovion 的所有者是 Sumitomo Chemical.
是其中之一......
Sumitomo Chemical 是一家在股票代码 4005 (JP) 下上市的公司。
Sumitomo Chemical 在 6 个国家有直接业务。Sumitomo Chemical 拥有 27家子公司，其中包括 Asahi Chemical、Covant Therapeutics 和 Datavant。
他们在：
药店
Sumitomo Chemical 拥有 1,842 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- BeiGene将改名为BeOne Medicines。 (公布2024十一月15号).
- GlycoMimetics and Crescent Biopharma have announced they will merge (公布2024十一月15号)..
- Grace Therapeutics将在Oct 25, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).
药店 行业的其他推荐联系人
消息
Sunovion 的最新新闻稿
- Sumitomo Pharma America to Present New Investigational Data at the 2024 American Society of Hematology Annual Meeting
- Sumitomo Pharma America Promotes Kenton Stewart to Chief Commercial Officer
- Sumitomo Pharma Announces that DSP-5336 Has Received FDA Fast Track Designation for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
- Sumitomo Pharma America Newsroom - News Releases
- Sumitomo Pharma Presents New Clinical Data on DSP-5336 at the European Hematology Association 2024 Congress
- Sumitomo Pharma Announces FDA Acceptance of Supplemental New Drug Application for Vibegron in Men with Overactive Bladder Symptoms Receiving Pharmacological Therapy for Benign Prostatic Hyperplasia
- Sumitomo Pharma Presents Urology and Oncology Data at AUA 2024 Annual Meeting
- Sumitomo Pharma Enters into an Agreement to Amend the Worldwide Collaboration and License Agreement for Four Psychiatry and Neurology Compounds Including Ulotaront with Otsuka
- Sumitomo Pharma Announces Availability of ORGOVYX® (relugolix) in Canada, the First and Only Oral Androgen Deprivation Therapy Treatment for Men with Advanced Prostate Cancer
- Sumitomo Pharma and Pfizer Canada Announce Availability of MYFEMBREE® in Canada
- View more press releases Close
关于 Sunovion 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Armin Szegedi 
